RHC has co-invested in some amazing deals and funds. You can still co-invest alongside us into early-stage and other deals. For example, we are LPs in Social Leverage and are co-investing with them.
Social Leverage Capital Fund IV, LP, a $99M seed-stage fund focused on backing exceptional founders in the Fintech, Enterprise SaaS and Consumer space.
Since our inception in 2009, we have been seed-stage investors in some of the world’s leading startups, including Robinhood, eToro, Kustomer, and Manscaped, and have made investments in over 150 seed-stage companies to date. As our fund size has grown, so has our ability to invest additional capital as the portfolio raises later-stage capital.
Talk to us about our different investment strategies!
Members of the Red Hook Capital team will be in Jonathan Club Santa Monica Beach Club for meeting with people and entities (family office, SPV, etc.) during the month of June.
FUND: Meeting one of our fund managers and HNWI that in less than 90 days is having distribution back to our Hybrid Fund.
DO GOOD FUND: Meeting one of our fund managers for SPAC and fund that is helping solar and water projects worldwide. Did I say he also makes movies for fun and family office has been doing projects worldwide for over 30 years?
JUST FUN: Dinner with other HNWI hosted by one of our fund managers (and largest investor) at Jonathan Club’s Santa Monica Beach Club with other family offices and HNWI.
Track record of co-investing with others to get returns;
Like minded investors that like to have fun (we had an amazing event at luxury car show at The Ritz-Carlton, Amelia Island);
Interview with RHC staff where we show you our PROOF of fund and investments with the understanding that you or your entity have $5 million invested in deals and are an active two-way investor (we invest in your deals and you invest in your deals).
Contact Sarah M at Sarah@RHC21.Fund or visit our staff on LinkedIn at Jack D or Charlette F anytime.
The company, a subsidiary of Lottomatica Holding, was acquired by Gamenet, via its financial sponsor Apollo Global Management, for EUR 950 million on May 12, 2021.
DEAL LEADER ( International Game Technology PLC )
Fabio Cairoli, 54, is Chief Executive Officer, Italy, and is responsible for managing all business lines, marketing services, and sales for the Company’s Italian operations. Through his leadership of the largest lottery operator in the world, Mr. Cairoli shares insights and best practices with other organizations in the Company. Mr. Cairoli joined the Company in 2012 as Senior Vice President of Business. He has more than 20 years of experience in consumer goods for multinational organizations, with both local and international expertise. He served as Group General Manager and Board Member of Bialetti Industrie, a world-renowned Italian manufacturer and retailer of stovetop coffee (espresso) makers and small household electrical appliances. During his tenure at Bialetti, he was responsible for turning around the business by refocusing strategy, streamlining costs, and optimizing the product portfolio and retail presence. Prior to Bialetti, Mr. Cairoli served as General Manager of Star Alimentare, a major Italian food company, and successfully relaunched a historical brand. Additionally, he spent part of his career with Julius Meinl Italia and with Motorola Mobile Devices Italy. He also spent 10 years with Kraft Foods in Italy and the U.K. in various capacities. Mr. Cairoli holds a Bachelor’s degree in Economics from the Catholic University in Milan.
Asapp, Inc., a New York based artificial intelligence research-driven company, raised $120m with Dragoneer Investment Group and Fidelity Management & Research leading the deal (see below form more information)
Smartly.io acquired Viralspace.ai, a Palo Alto, Calif.-based digital advertising A.I. startup. Viralspace investors have included Lightspeed Venture Partners and Quest Venture Partners.
Wysa, a Boston MA-based company that provides an AI-powered mental health platform, raised $5.5M in Series A funding
Cervest, a London UK-based company which specializes in Al-powered Climat Intelligence (CI) platform, raised $30m in Series A funding
SymphonyRM, a Palo Alto, CA-based provider of AI powered patient engagement solutions for health systems, raised $25m in Series B funding
Heru Inc., a Miami FL-based company developer of wearable AI-powered vision diagnostics and augmentation software, raised $30m in Series A funding
(See List of 50+ Deals Below)
DEAL OVERVIEW ( Asapp, Inc. )
Developer of a machine learning software designed to make customer experiences more productive. The company’s AI platform augments, automates and enhances conversations with customers to close more deals while focusing on complex and data-rich problems, enabling customer care teams, salespeople and other organizations to be more efficient and effective while realizing their full potential and increase efficiency.
The CEO, Mr. Gustavo Sapoznik, is a Co-Founder and serves as Chief Executive Officer and Board Member at Asapp.
DEAL VALUATION ( Asapp, Inc. )
The company raised $120 million of Series C venture funding in a deal co-led by Dragoneer Investment Group and Fidelity Management & Research on May 19, 2021, putting the company’s pre-money valuation at $1.48 billion. Telstra Ventures, March Capital, Emergence Capital Partners, 40 North Ventures, Victor Wang, Marcus Westin, John Doerr, John Chambers, and Euclidean Capital also participated in the round. The funds will be used to increase investment in its AI Native® and Customer Experience Performance (CXP) platform.
DEAL (Recent AI Deals)
Sempra Energy reached a definitive agreement to sell a 20% stake in the company to Kohlberg Kravis Roberts for $3.37 billion on April 4, 2021. The transaction values the company at approximately $25.2 billion. Proceeds from the sale will be used to help fund growth across Sempra Energy’s $32 billion capital program, which is centered on its U.S. utilities and to further strengthen its balance sheet. The company is being actively tracked by PitchBook.
The company raised $135 million of Series B venture funding in a deal led by Bain Capital Life Sciences on May 11, 2021, putting the company’s pre-money valuation at $335 million. Fairmount Funds Management, Driehaus Capital Management, Boxer Capital, Venrock, Deerfield Management, Fidelity Management & Research, Wellington Management, Viking Global Investors, Janus Henderson Investors, Avoro Capital and Logos Capital also participated in the round. The funds will be used to advance clinical trials and expand the discovery research pipeline. Previously, the company raised $50 million of Series A venture funding from Deerfield Management and other undisclosed investors on January 27, 2021, putting the company’s pre-money valuation at $20 million.
The company raised $114.76 million of Series D venture funding from Decheng Capital, Philos & Partners and Cormorant Asset Management on March 5, 2021, putting the company’s pre-money valuation at $350 million. Other undisclosed investors also participated in the round.
The company raised $114 million of Series A1 venture funding in a deal led by venBio on March 9, 2021, putting the company’s pre-money valuation at $184 million. OrbiMed, Vivo Capital, Qiming Venture Partners, New Science Ventures, Third Point Ventures, RTW Investments, Janus Henderson Investors, Wellington Management, Cormorant Asset Management, Surveyor Capital and Farallon Capital Management also participated in the round. The funds will be used to accelerate the clinical development of immunology programs and advance preclinical programs against novel drug targets with the prolific drug discovery engine.
The company raised $107 million of Series C venture funding in a deal led by venBio on March 1, 2021, putting the company’s pre-money valuation at $150 million. GV, PagsGroup, The Invus Group, HBM Healthcare Investments, 6 Dimensions Capital, Deerfield Management, Cormorant Asset Management, Farallon Capital Management, Blue Pool Capital, Casdin Capital and T. Rowe Price also participated in the round. The funds will be used to advance its lead, only-in-class Helicon peptides aimed at addressing substantial cancer patient populations into clinical development.
The company raised GBP 58.93 million of Series A venture funding from Access Industries, Lightspeed Venture Partners and Eldridge (Greenwich) on April 8, 2021, putting the pre-money valuation at GBP 260 million. The funds will be used to expand operations by acquiring studios and rollout the next generation of titles.
Rapid Micro Biosystems
The company raised $81 million of Series D1 venture funding in a deal led by D1 Capital Partners on March 16, 2021, putting the company’s pre-money valuation at $625 million. Bain Capital, Ally Bridge Group, Endeavour Vision, Xeraya Capital, Quaker Partners, Longitude Capital, Asahi Kasei Medical, BlackRock, T. Rowe Price, Adage Capital Management, Sunley House Capital Management and CaaS Capital Management also participated in the round. The funds will be used to accelerate the company’s growth.
The company raised $80 million of Series E venture funding in a deal led by Matrix Capital Management and Surveyor Capital on March 22, 2021, putting the company’s pre-money valuation at $200 million. Chiesi Ventures, Lundbeckfond Ventures, Medicxi, Ysios Capital, Advent Life Sciences, Arix Bioscience, Columbus Venture Partners, Velosity Capital, Rock Springs Capital and Adage Capital Management also participated in the round. The funds will be used to advance the clinical development of its VDC technology platform, including the pivotal Phase 3 program for AU-011, its lead candidate in development for the first-line treatment of choroidal melanoma, and ongoing research for additional programs in ocular oncology, as well as expanding the VDC technology into bladder cancer, the first non-ophthalmic solid tumor indication.
The company raised $70 million of Series C venture funding in a deal led by Ontario Teachers’ Pension Plan on May 20, 2021, putting the company’s pre-money valuation at $296.26 million. The Goldman Sachs Group and 9 other investors also participated in the round. The company intends to use the fund to accelerate the development of the company’s industry-leading data and suite of products to serve institutions with diverse clients and complex risk exposure.
The company raised $50 million of venture funding in a deal led by PeakSpan Capital on April 16, 2021, putting the company’s pre-money valuation at $150 million. The funds will be used to continue its history of high caliber innovation velocity and dedication to delivering superior customer success at scale, for the most demanding customers across the globe.
The company raised $40 million of Series A venture funding in a deal led by HBM Healthcare Investments and Samsara BioCapital on April 6, 2021, putting the company’s pre-money valuation at $37.5 million. Adams Street Partners and Catalys Pacific also participated in the round. The company intends to use the fund to complete a phase 2 proof-of-concept study for its lead experimental hypertension treatment, MLS-101 and for preparatory work for late-stage testing of the therapy.
Fenergo, an Ireland-based digital enabler of client and regulatory technology for financial services, raised $80 million. DXC led the round and was joined by the venture arm of Dutch bank ABN Amro.
Kajabi, an Irvine, Calif.-based e-commerce platform for entrepreneurs in the knowledge economy, raised $550m in growth equity financing that values the company at over $2 billion
DoubleVerify, launched Initial Public Offering
Upon the completion of the acquisition, RealPage shareholders were entitled to receive $88.75 in cash per share. The price per share represents a 30.8 percent premium to the company’s closing share price of $67.83 on December 18, 2020, and a premium of 36.5 percent over RealPage’s 30-day volume-weighted average share price through December 18, 2020. With the completion of the acquisition, RealPage becomes a privately-held company, and its common stock ceased trading and will no longer be listed on the Nasdaq stock exchange.
LEADERSHIP (CEO RealPage)
Mr. Stephen Winn is the Founder and serves as Chairman of the Board & Chief Executive Officer at RealPage. He has served as RealPage chief executive officer, chairman of the board, and a member of our board of directors since November 1998. Prior to RealPage, Mr. Winn served in various executive positions, including president of Research Institute of America, a provider of information services to the accounting industry and a wholly owned subsidiary of Thomson Reuters Corporation, and president and chief executive officer of Computer Language Research Inc., a publicly traded company focused on tax compliance, tax research and accounting software, which was acquired by Thomson Reuters Corporation. Mr. Winn was one of five people recognized by the National Apartment Association as a leader in the multifamily industry. Accounting Today recognized him as one of the 100 most influential people. In June 2012, Mr. Winn was an Ernst & Young Entrepreneur of the Year 2012 Southwest Area North Award recipient. He is an active member of the National Apartment Association and National Multifamily Housing Council. Mr. Winn received his Bachelor of Science in electrical engineering from the University of Texas at Austin and his Master of Science in management from Stanford University.
OTHER DEALS (PE SOFTWARE DEALS MONEY RAISED TO DATE IN MILLIONS)
Goldbelly, a New York City?-based maker of a food e-commerce platform, raised $100 million in Series C funding. Spectrum Equity led the round and was joined by investors including Intel Capital. (DISCLOSURE: A Red Hook Capital Fund has co-invested in the D round with Spectrum Equity)
Coiled, a New York-based machine-learning and A.I. data company, raised $21 million in funding. Bessemer Venture Partners led the round. (DISCLOSURE: Red Hook Capital has co-invested in deals with Bessemer Venture Partners )
Houm, a Chile-based all-in-one platform for homeowners to rent and sell their properties, raised $8 million in seed funding. Investors included Y Combinator, Goodwater Ventures, OneVC, Vast VC, Liquid2, and Myelin. (DISCLOSURE: Red Hook Capital has co-invest in deal with Y Combinator)
Platinum Equity agreed to acquire Game Taco, a Sausalito, Calif.-based skill-based mobile gaming platform. Game Taco will also acquire WorldWinner, a skill-game company, from GSN Games, which is owned by Sony Pictures Entertainment. Financial terms weren’t disclosed. (DISCLOSURE: Red Hook Capital has advised Platinum Equity on other mergers and place bids on Platinum Equity portfolio companies in the past).
Ankorstore, a Paris-based curated marketplace for independent brands and retailers, raised $100 million in series B funding. Tiger Global and Bain Capital Ventures led the round and were joined by investors including Index Ventures, Global Founders Capital, Alven, and Aglaé. (DISCLOSURE: Red Hook Capital has co-invest in deal with Tiger Global)
MasterClass is raising $225 million in a new round of funding that it will use to launch a new enterprise business and expand internationally.
It more than triples the start-up’s valuation to $2.75 billion, according to sources.
The Series F was led by Fidelity, with participation from Baillie Gifford, Eldridge, IVP and NEA.
Online learning platform MasterClass has been valued at $2.75 billion in a new round of funding. That’s more than triple its valuation from 3q2020, according to Pitchbook.
MasterClass, the streaming platform that makes it possible for anyone to learn from the best, today announced that it has raised $225M in Series F funding, led by Fidelity Management & Research Company and with participation from new investors including Baillie Gifford, Balyasny Asset Management and Eldridge together with existing investors IVP, Javelin, NEA and Owl Ventures. Disclosure: This report is a portfolio company of Red Hook Capital that co-invested in the deal through a SPV in this round).
MasterClass relies on a subscription model for revenue. An annual subscription costs $180 and allows users unlimited access. For EBITDA companies, the number of subscribers could influence the valuation or a multiple of EBITDA.
A member of the The Capitalization Report would be happy to discuss in details valuation of this company with the requirement that they are an accredited investor with proof of funds (can use our PROOF program) or an owner in a company with EBITDA greater than $3 million.
CEO & GENERAL PARTNERS CLOSING DEALS
David Rogier is profiled today for raising $225 million in a new round of funding that it will use to launch a new enterprise business and expand internationally
David Rogier is the founder and CEO of MasterClass, the streaming platform where anyone can learn from the world’s best across a wide range of subjects. As a kid, Rogier loved learning but often struggled in school. In 2015, he created MasterClass to reinvent the traditional model and provide life-long learning opportunities for everyone.
MasterClass has since transformed the online learning category providing intimate access to over 90 of the world’s best practitioners.
In 2020, David Rogier was named one of the most influential leaders in media and entertainment on Fortune’s “40 under 40” list and as one of Variety’s Hollywood New Leaders.
RECENT DEALS THAT CLOSED OF INTEREST
Healogics, a Jacksonville, Fla.-based provider of wound care, raised $240 million. Clayton Dubilier & Rice, Partners Group, and Northwestern Mutual invested $75 million. Marathon Asset Management invested some $165 million (DISCLOSURE: A member of Red Hook Capital S.E.A. was a former board member of Northwestern Mutual).Merge, a San Francisco and New York City-based business-to-business API company, raised $4.5 million in seed funding. NEA led the round. (DISCLOSURE: A Red Hook Capital Fund has invested in NEA Fund).
PROVACTIVE STATEMENT: “STOP! No more back to normal but to the future please!” – JDM 210512
BEST QUOTE: The Best Way To Predict The Future Is To Create It – Unknow or basic law?
1st Get these crazy people off the air that are pro and con COVID as they do not know the truth and make it up as they go along (#1 that media whore whos name should not be named but let us call him Anthony Fauci as I would not call him a “Dr.” and others (like few crazy people on Fox News and CNN).
2nd Focus on the future. Stop making us wear these mask that make it hard to hear anything anyone says and breath. FYI: If you learned to live with these cheap mask, you are being fooled on their safety value (you are a sheep)! PLEASE create a mask with cleaner air for me to breath!
YES! Focus on the future and stop this crazy “new normal” and do no look to back to normal but the future!